ICA-027243 is primarily investigated for its potential therapeutic applications, particularly in the field of oncology. It functions as a selective inhibitor targeting specific signaling pathways involved in cancer cell proliferation and survival. Research suggests that it may be effective in treating certain types of cancers by disrupting the growth and division of malignant cells. Additionally, it is being studied for its role in enhancing the efficacy of existing cancer therapies when used in combination treatments. Preclinical studies have shown promising results, indicating its potential as a targeted therapy for tumors resistant to conventional treatments. Further clinical trials are necessary to fully understand its safety, efficacy, and potential applications in human medicine.